Evrim Resources Corp (EMRRF) 0.2324 $EMRRF Evrim

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evrim Resources Corp (EMRRF) 0.2324 $EMRRF

Evrim Resources Expands High Grade Vein Field at Cerro Cascaron
ACCESSWIRE - Wed Aug 17, 9:41AM CDT
VANCOUVER, BC / ACCESSWIRE / August 17, 2016 / Evrim Resources Corp. (TSX.V: EVM) ("Evrim" or the "Company" announces new exploration results at the Company's 100% owned Cerro Cascaron project in Chihuahua, Mexico. The large, zoned, and high grade gold vein field at Cerro Cascaron has now been extended to 18 square kilometres and sampling within the field has identified several drill targets. Cerro Cascaron is a large, low to intermediate sulphidation epithermal gold target located in Sierra Madre Occidental in Chihuahua, approximately 55 kilometres southeast of Goldcorp Inc.'s past-producing El Sauzal gold mine.
EVM.VN: 0.290 (unch), GG: 16.83 (+1.10)

Evrim Resumes Exploration on High Grade Epithermal Vein Field at Cerro Cascaron
ACCESSWIRE - Wed Jun 08, 7:55AM CDT
VANCOUVER, BC / ACCESSWIRE / June 8, 2016 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" announces exploration results and the resumption of exploration activity at the Company's 100% owned Cerro Cascaron project in Chihuahua, Mexico. A large, zoned, and high grade gold vein field has been defined at Cerro Cascaron and the next phase of exploration is aimed at mapping the extent of the system and defining drill targets. Cerro Cascaron is a low sulphidation epithermal gold target located in the dissected volcanic terrains of the Sierra Madre Occidental in Chihuahua, approximately 55 kilometres southeast of Goldcorp Inc.'s past-producing El Sauzal gold mine.
EVM.VN: 0.290 (unch), GG: 16.83 (+1.10)

Evrim Appoints Charles Funk VP New Opportunities & Exploration
ACCESSWIRE - Thu May 12, 7:36AM CDT
VANCOUVER, BC / ACCESSWIRE / May 12, 2016 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" is pleased to announce the appointment of Mr. Charles Funk as Vice President of New Opportunities and Exploration. Charles will be a key member of Evrim's exploration and business development team.
EVM.VN: 0.290 (unch)

Evrim Expands Gold Mineralization at Cerro Cascaron
ACCESSWIRE - Thu Apr 14, 8:33AM CDT
VANCOUVER, BC / ACCESSWIRE / April 14, 2016 / Evrim Resources Corp. (TSX.V: EVM) ("Evrim" or the "Company" is pleased to announce results from an exploration program on its 100% owned Cerro Cascaron project in Chihuahua, Mexico. Cerro Cascaron is an early stage target covering 69 square kilometres of ground prospective for epithermal gold-silver deposits. The property is favorably situated in the dissected volcanic terrains of the Sierra Madre Occidental in Chihuahua, approximately 55 kilometres southeast of Goldcorp Inc.'s past-producing El Sauzal gold mine. Cerro Cascaron represents one of the few untested targets in the trend.
EVM.VN: 0.290 (unch), GG: 16.83 (+1.10)

Evrim Advances the Ball Creek Project
ACCESSWIRE - Mon Jan 25, 7:39AM CST
VANCOUVER, BC / ACCESSWIRE / January 25, 2016 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" is pleased to announce the results of exploration and targeting work on the Ball Creek Project. Geological mapping, sampling and data reinterpretation have identified a significant number of untested drill targets as well as broadened the Company's understanding of lithologic, structural and alteration controls on mineralization. Ball Creek is an early stage exploration property prospective for copper-gold-molybdenum porphyry and epithermal gold-silver deposits. The project covers a 520 square kilometre area in the Golden Triangle in northwest British Columbia.
EVM.VN: 0.290 (unch)

Evrim Acquires Cerro Cascaron Gold Property
ACCESSWIRE - Mon Jan 18, 7:36AM CST
VANCOUVER, BC / ACCESSWIRE / January 18, 2016 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" is pleased to announce that it has acquired the Cerro Cascaron project in Chihuahua, Mexico. Cerro Cascaron is an early stage target covering 69 square kilometres of ground prospective for epithermal gold-silver deposits. The project was identified through the Company's generative programs in 2015. The property is favorably situated in the dissected volcanic terrains of the Sierra Madre Occidental in Chihuahua, approximately 70 kilometres southeast of Goldcorp Inc.'s past-producing El Sauzal gold mine. Cerro Cascaron represents one of the few untested targets in the trend.
EVM.VN: 0.290 (unch), GG: 16.83 (+1.10)

Evrim Closes Non-brokered Private Placement
ACCESSWIRE - Thu Dec 17, 3:21PM CST
VANCOUVER, BC / ACCESSWIRE / December 17, 2015 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" announces that it has closed the non-brokered private placement announced on November 18, 2015 (the "Private Placement". The Company has issued 12,568,800 units for gross proceeds of $1,508,256. Each Unit consisted of one common share and one non-transferable share purchase warrant (a "Warrant". Each Warrant is exercisable into one common share at a price $0.25 until December 16, 2020.
EVM.VN: 0.290 (unch)

Evrim Announces $1.8 Million Non-Brokered Private Placement
ACCESSWIRE - Wed Nov 18, 4:24PM CST
VANCOUVER, BC / ACCESSWIRE / November 18, 2015 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" announces a 15,000,000 unit non-brokered private placement at $0.12 per unit for gross proceeds of $1.8 million. Each Unit will consist of one common share and one non-transferable share purchase warrant (a "Warrant". Each Warrant is exercisable into one common share at a price $0.25 for five years from the date of closing (the "Closing Date".
EVM.VN: 0.290 (unch)

Paget Obtains Shareholder Approval for Vending of the Ball Creek Project, BC
Marketwired - Tue Jun 16, 1:01PM CDT
Paget Minerals Corp. (TSX VENTURE: PGS), ("Paget" or the "Company" is pleased to announce that further to the Company's news release on April 27, 2015, the Ball Creek agreement (the "Agreement" between Paget and Evrim Resources Corp. (TSX VENTURE: EVM) ("Evrim" has been approved by Paget's shareholders. The Agreement remains subject to acceptance by the TSX Venture Exchange.
EVM.VN: 0.290 (unch), PGS.VN: 0.065 (unch)

Evrim Formally Acquires the Ball Creek Project in British Columbia
ACCESSWIRE - Tue Jun 16, 7:35AM CDT
VANCOUVER, BC / ACCESSWIRE / June 16, 2015 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" is pleased to announce that further to the Company's news release on April 27, 2015, the Ball Creek agreement (the "Agreement" between Evrim and Paget Minerals Corp. ("Paget" has been approved by Paget's shareholders. Ball Creek is an early stage exploration target prospective for copper-gold-molybdenum porphyry and epithermal gold-silver deposits. The project covers a 520 square kilometre area in the Golden Triangle in northwest British Columbia.
EVM.VN: 0.290 (unch)

Evrim Appoints Dr. John Thompson to the Board of Directors
ACCESSWIRE - Wed May 13, 7:35AM CDT
VANCOUVER, BC / ACCESSWIRE / May 13, 2015 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" is pleased to announce the appointment of Dr. John Thompson to the Company's Board of Directors. John will be a key contributor to Evrim's geoscience team, and identify new business opportunities.
EVM.VN: 0.290 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading